Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|April 3, 2019
Pericytes in the GutMarta Ramirez, Nuria Pell, Marc Mejias, et al.Journal of Cellular and Molecular Medicine|January 16, 2008
The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in ratsMarc Mejias, Ester Garcia-Pras, Carolina Tiani, et al.Hepatology (Baltimore, Md.)|January 13, 2009
Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic ratsMarc Mejias, Ester Garcia-Pras, Carolina Tiani, et al.Scientific Reports|November 3, 2017
Therapeutic siRNA targeting endothelial KDR decreases portosystemic collateralization in portal hypertensionJavier Gallego, Ester Garcia-Pras, Marc Mejias, et al.Journal of Hepatology|March 9, 2010
Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertensionMarc Mejias, Ester Garcia-Pras, Javier Gallego, et al.Journal of Hepatology|May 17, 2005
Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive ratsMercedes Fernandez, Marc Mejias, Bernhard Angermayr, et al.Hepatology (Baltimore, Md.)|July 27, 2007
Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in ratsMercedes Fernandez, Marc Mejias, Ester Garcia-Pras, et al.Journal of Hepatology|February 7, 2006
Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive ratsBernhard Angermayr, Marc Mejias, Jorge Gracia-Sancho, et al.Gut|July 21, 2006
NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive ratsBernhard Angermayr, Mercedes Fernandez, Marc Mejias, et al.Gut|May 23, 2014
Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive ratsMarc Mejias, Laura Coch, Annalisa Berzigotti, et al.Pageof 2